Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||||
| Earning before tax | 279.77%2.96B | 251.70%1.95B | 200.64%780.4M | 336.59%553.47M | 229.09%259.58M | -17.79%126.77M | --78.88M | 28.33%154.21M | --120.17M |
| Profit adjustment | |||||||||
| Interest (income) - adjustment | -368.46%-2.79M | -664.29%-2.68M | -114.39%-596K | -108.33%-350K | -198.92%-278K | -36.59%-168K | ---93K | 36.92%-123K | ---195K |
| Impairment and provisions: | -182.72%-1.79M | 7.12%6.98M | 22.60%2.16M | 379.34%6.52M | 54.61%1.76M | 113.17%1.36M | --1.14M | -59.18%638K | --1.56M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --631K | ---- | ---- | --1.27M |
| -Impairmen of inventory (reversal) | 5.44%1.51M | -69.63%530K | 99.03%1.43M | 239.49%1.75M | 101.68%720K | 834.55%514K | --357K | -37.50%55K | --88K |
| -Impairment of trade receivables (reversal) | -809.00%-3.39M | 70.48%6.03M | -51.91%478K | 1,922.68%3.54M | 52.22%994K | -139.59%-194K | --653K | 730.51%490K | --59K |
| -Other impairments and provisions | -62.90%92K | -65.67%425K | 427.66%248K | 202.69%1.24M | -63.57%47K | 339.78%409K | --129K | -37.58%93K | --149K |
| Asset sale loss (gain): | -81.10%286K | 1,099.07%3.85M | 366.98%1.51M | -75.31%321K | --324K | 12,900.00%1.3M | ---- | -98.85%10K | --871K |
| -Loss (gain) on sale of property, machinery and equipment | -81.10%286K | 1,099.07%3.85M | 366.98%1.51M | -75.31%321K | --324K | 12,900.00%1.3M | ---- | -98.85%10K | --871K |
| Depreciation and amortization: | 58.05%131.97M | 51.41%181.34M | 58.30%83.5M | 43.91%119.77M | 39.18%52.75M | 35.39%83.22M | --37.9M | -12.56%61.47M | --70.3M |
| -Amortization of intangible assets | 394.43%14.91M | 15.36%3.18M | 155.94%3.02M | 7.60%2.76M | -6.14%1.18M | -22.55%2.57M | --1.26M | -12.52%3.31M | --3.79M |
| Financial expense | 293.94%42.21M | 67.39%30.43M | 26.93%10.71M | 7.12%18.18M | -1.55%8.44M | 45.43%16.97M | --8.57M | 34.01%11.67M | --8.71M |
| Special items | 498.40%83.18M | 251.52%28.4M | 647.77%13.9M | 553.82%8.08M | 170.85%1.86M | -143.64%-1.78M | ---2.62M | 193.51%4.08M | ---4.36M |
| Operating profit before the change of operating capital | 260.79%3.22B | 210.90%2.19B | 174.81%891.59M | 210.08%705.99M | 162.12%324.43M | -1.84%227.68M | --123.77M | 17.71%231.96M | --197.05M |
| Change of operating capital | |||||||||
| Inventory (increase) decrease | -447.30%-4.6B | -508.91%-2.81B | -436.52%-839.86M | -1,227.91%-461.89M | -2,076.24%-156.54M | 61.32%-34.78M | --7.92M | -18.29%-89.92M | ---76.02M |
| Accounts receivable (increase)decrease | -610.42%-39.94M | -54.04%-430.65M | 111.91%7.82M | -6,500.41%-279.57M | -238.76%-65.67M | 115.77%4.37M | --47.33M | -1,587.09%-27.7M | ---1.64M |
| Accounts payable increase (decrease) | 26.01%271.87M | 182.52%379.18M | 243.21%215.76M | 11,630.24%134.21M | 445.06%62.86M | -106.59%-1.16M | ---18.22M | 127.15%17.65M | ---65.03M |
| prepayments (increase)decrease | -766.41%-444.76M | -638.51%-156.09M | -3,249.33%-51.33M | -7.34%-21.14M | 124.35%1.63M | -229.43%-19.69M | ---6.69M | 52.66%15.21M | --9.97M |
| Special items for working capital changes | -66.87%5.79M | -190.47%-17.88M | 568.52%17.48M | 410.96%19.76M | 370.60%2.61M | 47.31%3.87M | ---966K | 156.99%2.63M | ---4.61M |
| Cash from business operations | -757.21%-1.59B | -965.85%-843.02M | 42.59%241.45M | -45.99%97.36M | 10.57%169.33M | 20.32%180.28M | --153.15M | 150.84%149.83M | --59.73M |
| Other taxs | -259.92%-631.33M | -205.83%-388.13M | -213.03%-175.41M | -297.26%-126.91M | -191.72%-56.03M | 33.03%-31.95M | ---19.21M | -49.99%-47.7M | ---31.8M |
| Interest received - operating | 368.46%2.79M | 664.29%2.68M | 114.39%596K | 108.33%350K | 198.92%278K | 36.59%168K | --93K | -36.92%123K | --195K |
| Net cash from operations | -3,424.52%-2.22B | -4,107.67%-1.23B | -41.33%66.64M | -119.66%-29.2M | -15.26%113.58M | 45.24%148.5M | --134.03M | 263.61%102.25M | --28.12M |
| Cash flow from investment activities | |||||||||
| Sale of fixed assets | ---- | ---- | ---- | 1,515.00%323K | 8,950.00%181K | -91.63%20K | --2K | -56.07%239K | --544K |
| Purchase of fixed assets | -75.93%-57.28M | -19.11%-70.92M | -87.09%-32.56M | -72.07%-59.54M | 20.10%-17.4M | -10.95%-34.6M | ---21.78M | -181.91%-31.19M | ---11.06M |
| Net cash from investment operations | -75.93%-57.28M | -19.76%-70.92M | -89.05%-32.56M | -71.23%-59.22M | 20.93%-17.22M | -11.74%-34.58M | ---21.78M | -194.22%-30.95M | ---10.52M |
| Net cash before financing | -6,768.94%-2.27B | -1,369.67%-1.3B | -64.63%34.08M | -177.61%-88.41M | -14.16%96.35M | 59.78%113.92M | --112.25M | 305.07%71.3M | --17.6M |
| Cash flow from financing activities | |||||||||
| New borrowing | 1,229.44%2.13B | 1,068.95%1.49B | --160M | -30.74%127.04M | ---- | -7.88%183.41M | --7.95M | 15.28%199.09M | --172.7M |
| Refund | -91.82%-305M | -65.94%-229M | -1,035.71%-159M | 25.71%-138M | 25.33%-14M | 6.63%-185.75M | ---18.75M | -55.96%-198.95M | ---127.56M |
| Issuing shares | 202.15%2.5B | 328.84%950.97M | --826.85M | --221.75M | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -1,235.79%-46.91M | -352.79%-25.9M | -19.29%-3.51M | 3.30%-5.72M | 1.74%-2.94M | -4.99%-5.92M | ---3M | 10.73%-5.64M | ---6.31M |
| Dividends paid - financing | ---89.73M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --355K |
| Issuance expenses and redemption of securities expenses | 49.38%-15.36M | ---55.4M | ---30.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | -54.43%566K | -99.11%11K | 648.19%1.24M | 885.71%1.24M | -95.48%166K | --126K | -6.96%3.68M | --3.95M |
| Net cash from financing operations | 464.15%4.06B | 1,880.65%1.96B | 1,361.27%720.29M | 224.86%98.97M | -36.54%-57.11M | -42.35%-79.27M | ---41.83M | -316.17%-55.68M | ---13.38M |
| Effect of rate | -2,435.43%-7.66M | 289.13%1.9M | -158.19%-302K | -325.39%-1M | 80.84%519K | 413.38%445K | --287K | -51.06%-142K | ---94K |
| Net Cash | 137.40%1.79B | 6,159.26%660.92M | 1,822.19%754.37M | -69.52%10.56M | -44.27%39.25M | 121.91%34.65M | --70.43M | 269.89%15.61M | --4.22M |
| Begining period cash | 949.07%732.65M | 15.85%69.84M | 15.85%69.84M | 139.31%60.28M | 139.31%60.28M | 159.18%25.19M | --25.19M | 73.80%9.72M | --5.59M |
| Cash at the end | 205.36%2.52B | 949.07%732.65M | 723.52%823.9M | 15.85%69.84M | 4.32%100.05M | 139.31%60.28M | --95.9M | 159.18%25.19M | --9.72M |
| Cash balance analysis | |||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.